Related Experiment Videos
Genetic conditions for the release of a lymphokine "lymph node activating factor"
Folia Biologica
|January 1, 1981
Abstract:
The release of a lymph node activating factor is controlled by the genetic difference in the I region of the H-2 complex. Incompatibility at IA and IE loci is of decisive importance.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system.
Journal of psychiatric and mental health nursing·2015
Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice.
Annals of the rheumatic diseases·2005
Strong association of HLA-B27 heavy chain with beta 2-microglobulin.
Human immunology·2001
Research on the Diagnostic Potential of miR-383-5p in Rheumatoid Arthritis.
Folia biologica·2026
Inflammatory bowel disease treatment: Mechanisms to clinical translation (Review).
International journal of molecular medicine·2026
Methodological strategies for mapping HLA susceptibility loci in vitiligo: A focused minireview.
World journal of methodology·2026
Modality matters: Effect of dialysis modality on soluble intercellular adhesion molecule-1 in children on regular hemodialysis.
World journal of clinical pediatrics·2026
Potential diagnostic role of urinary exosomal microRNAs in immunoglobulin A nephropathy: A case-control study.
World journal of nephrology·2026